Overview

Director, Program Management Office (PMO) Jobs in Waltham, MA at Corindus



Title: Director, Program Management Office (PMO)

Company: Corindus

Location: Waltham, MA

Salary: $200K – $250K*

Category: Healthcare

Job Description

POSITION SUMMARY

The Director, Program Management Office is responsible for leadership and oversight of Corindus’ portfolio of technology and product development projects. Leadership responsibility spans all phases of medical device development from concept through commercialization. Works closely with a cross-functional leadership team to establish project-portfolio priorities, manage resource allocation, develop timelines and budgets, and drive execution to meet agreed upon timelines, cost and quality targets. Develops and implements frameworks and processes for project-portfolio management (PPM). Proactively leads continuous improvement initiatives to improve execution speed, communication, and organizational performance. Ensures that all components of development programs are accounted for and connected, and that the execution of each program is fully aligned with its scope and strategic intent. Responsible for functional management of the development organization’s program and project managers.

PRIMARY RESPONSIBILITIES

Drive adoption of tools and best practices for efficient, rapid, and predictable program execution using contemporary tools and practices such as Agile and Lean Development

Serve as a thought partner to senior management and technical leads on program design and strategy

Oversee workflow across all tracks of product development work – anticipating gaps and identifying synergies and dependencies between programs and functions

Provide guidance on prioritization of tasks across programs to avoid or minimize the impact of resource conflicts

Improve and maintain a rigorous development process supporting design control requirements in compliance with QSR 820.1 (FDA Medical Device)

Navigate program teams through a disciplined stage gate process and other go/no-go decisions by executive leadership; ensure decisions are informed by a balanced and clearly articulated representation of relevant data

Identify and proactively manage development risks and issues that could impact program cost and schedules across the portfolio; ensure solutions are successfully implemented by removing technical and/or organizational roadblocks

Create and implement an ongoing portfolio performance measurement system; monitor performance to understand impact of program status on company financials and strategic objectives

Design and facilitate broad interventions to resolve difficult team or organizational performance issues

Cultivate a high-performing organization which fosters teamwork and collaboration; lead by example through authentic communication and a solution-oriented approach

CHARACTERISTICS

A passion and strong instincts for connecting strategy to detail and follow-through

Ability to identify priorities and shift focus between the big picture and technical details of complex product development projects

Proactive problem solver and gifted multi-tasker with the ability to drive teams to success

A clear, direct communication style, with the capacity to read the room and adjust accordingly

Nimble, ability to quickly pivot, make sense of change, and point teams in the right direction

Presence and diplomacy that allow you to influence teams

Strong analytical and problem-solving skills

DESIRED SKILLS AND EXPERIENCE

B.S. in Electrical Engineering, Mechanical Engineering, Computer Science or related discipline required, M.S. preferred

10+ years of program management experience in medical devic…

 

About Corindus



Corindus Vascular Robotics (Corindus, Inc.) was founded in 2002 by Rafael Beyar, an interventional cardiologist, and Tal Wenderow. Its goal is to use remote control and robotics to move coronary guidewires and balloon/stent catheters. Corindus, Inc. is based in Waltham, Massachusetts. The company’s FDA-cleared CorPath® System is the first medical device that allows interventional cardiologists to manipulate guidewires and balloon/stents from an interventional cockpit. The company went public in August 2014 and currently trades on the New York Stock Exchange with the ticker symbol CVRS.